Raymond James Financial Inc Novo Nordisk A S Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Raymond James Financial Inc holds 4,707,166 shares of NVO stock, worth $325 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
4,707,166Holding current value
$325 Million% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,817Shares Held
339MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC18.8MShares$1.3 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.07 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$898 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$874 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$844 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $156B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...